LITTLE ELM, Texas – Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00
LITTLE ELM, Texas – Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $7.6 million for the first three months of 2024 and an operating loss of nearly $3.0 million for the period, as compared to total net sales for the same period last year of $11.0 million
LITTLE ELM, Texas – Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2023. Further details concerning the results of operations as well as other matters are available in Retractable’s Form 10-K filed on March 29, 2024 with the U.S. Securities and
LITTLE ELM, Texas – Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts of $39,050.00 and $18,561.25, respectively. Dividends have accrued at $1.00
Nursing is home to a devoted group of people that spend their lives in the service of others. Claire Fagin, PhD, RN spent her lifetime diligently in service to others. She passed away on January 16, 2024. At the age of 97 she left behind a permanent imprint of vision,
Over more than a half century, the University of North Texas Health Science Center in Fort Worth has grown and evolved (from what initially was the Texas College of Osteopathic Medicine) into an institution that includes schools of public health, biomedical science, pharmacy, and other healthcare professions.
Texas Woman’s University (TWU) recently broke ground on a new $107 million health sciences center in Denton. The 136,000-square-foot facility will sit on seven acres adjacent to the TWU campus.
How will global warming and major climate events affect healthcare systems in the United States and elsewhere? And how will they affect nurses and their work?
Retractable Technologies, Inc. (RTI) proudly manufactures retractable safety needle devices. VanishPoint® products have been in development since 1989, and like all revolutionary designs, the process to market has been arduous. Grants awarded by the National Institutes of Health helped to bring the early designs into prototypes for clinical trials. Five
You may have heard about the November 30, 2023 FDA Safety Communication, “Evaluating Plastic Syringes Made in China for Potential Device Failures.” Retractable Technologies Inc. wants to assure you that the safety communication does not refer or relate to VanishPoint safety syringes from Retractable Technologies. The FDA identified quality issues